KRON4 News

World's First -- XellSmart's Allogeneic iPSC-derived Regenerative Cell Therapy for Spinal Cord Injury Officially Approved by the U.S. FDA for a Registrational Phase I Clinical ...

SUZHOU, China, May 25, 2025 /PRNewswire/ -- In May 2025, XellSmart Biopharmaceutical (Suzhou/Shanghai) Co., Ltd. officially announced that XellSmart-developed off-the-shelf allogeneic iPSC-derived ...
ALS News Today

Scientists grow specialized motor neurons to aid in ALS research

Scientists developed a technique to grow cells that control voluntary movement, a discovery that could aid ALS and spinal injury research.
Becker's ASC

Central Phoenix Surgical Center Adds Progenitor Cell Therapy

Central Phoenix Surgical Center has received approval from various regulatory bodies to add Progenitor Cell Therapy to its list of interventional pain services. Progenitor Cell Proteins are used by ...
KXAN

XellSmart Completed World's First Patient Dosing in its Registrational Clinical trial for iPSC-derived Subtype-specific Neural Cell Therapy for Spinal Cord Injury

SUZHOU, China, July 28, 2025 /PRNewswire/ -- XellSmart Biopharmaceutical (Suzhou/Shanghai) Co., Ltd. achieved a significant milestone in its "world's first" China NMPA & US FDA-approved registrational ...